Fig. 5From: Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 casesRate of revising by pathologists according to the artificial intelligence (AI) analyzer’s results, when one, two, or all three pathologists revisited (ER: estrogen receptor, HER2: human epidermal growth factor receptor 2, PR: progesterone receptor)Back to article page